Sanctuary Advisors LLC Purchases New Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sanctuary Advisors LLC purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 19,329 shares of the medical instruments supplier’s stock, valued at approximately $481,000.

Several other hedge funds also recently made changes to their positions in the company. Teachers Retirement System of The State of Kentucky raised its stake in DENTSPLY SIRONA by 264.5% during the second quarter. Teachers Retirement System of The State of Kentucky now owns 70,598 shares of the medical instruments supplier’s stock valued at $1,758,000 after buying an additional 51,228 shares during the last quarter. Brandes Investment Partners LP raised its stake in DENTSPLY SIRONA by 102.7% during the second quarter. Brandes Investment Partners LP now owns 46,638 shares of the medical instruments supplier’s stock valued at $1,166,000 after buying an additional 23,626 shares during the last quarter. Creative Planning raised its stake in DENTSPLY SIRONA by 53.9% during the second quarter. Creative Planning now owns 16,540 shares of the medical instruments supplier’s stock valued at $412,000 after buying an additional 5,793 shares during the last quarter. Algert Global LLC raised its stake in DENTSPLY SIRONA by 123.9% during the second quarter. Algert Global LLC now owns 32,083 shares of the medical instruments supplier’s stock valued at $799,000 after buying an additional 17,753 shares during the last quarter. Finally, Scientech Research LLC purchased a new position in DENTSPLY SIRONA during the second quarter valued at $846,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Stock Up 1.4 %

DENTSPLY SIRONA stock opened at $24.64 on Thursday. The stock has a market cap of $4.99 billion, a PE ratio of -28.65, a price-to-earnings-growth ratio of 1.17 and a beta of 1.00. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. DENTSPLY SIRONA Inc. has a one year low of $23.58 and a one year high of $37.60. The stock has a fifty day moving average of $25.27 and a 200 day moving average of $26.88.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm’s revenue was down 4.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.51 EPS. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.60%. The ex-dividend date was Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -74.42%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on XRAY shares. Needham & Company LLC reiterated a “buy” rating and set a $34.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Evercore ISI decreased their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Stifel Nicolaus decreased their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Finally, Barrington Research restated an “outperform” rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $33.22.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.